Dynavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. 

CEO
Ryan Spencer
CEORyan Spencer
Employees
405
Employees405
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
1996
Founded1996
Employees
405
Employees405

DVAX Key Statistics

Market cap
1.20B
Market cap1.20B
Price-Earnings ratio
-21.91
Price-Earnings ratio-21.91
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$10.46
High today$10.46
Low today
$10.20
Low today$10.20
Open price
$10.32
Open price$10.32
Volume
1.71M
Volume1.71M
52 Week high
$14.63
52 Week high$14.63
52 Week low
$9.20
52 Week low$9.20

DVAX News

Simply Wall St 2d
How Does Dynavax Stack Up After 7% Climb and New Product Developments?

Thinking about what to do with Dynavax Technologies stock right now? You are definitely not alone. With the share price closing recently at $10.46, there are pl...

How Does Dynavax Stack Up After 7% Climb and New Product Developments?
TipRanks 4d
Dynavax Technologies Advances in Pneumonic Plague Vaccine Study

Dynavax Technologies ((DVAX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own DVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.